🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 16 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
07/11/2005 35,50 35,50 34,70 35,00 +1,16% 2,25% 5.410
04/11/2005 35,90 35,90 34,40 34,60 -1,70% 4,18% 9.260
03/11/2005 35,80 36,00 34,10 35,20 -1,12% 5,31% 14.010
02/11/2005 35,00 35,60 34,40 35,60 +3,19% 3,43% 8.030
01/11/2005 35,00 35,90 33,70 34,50 +0,58% 6,29% 10.110
31/10/2005 32,10 35,70 31,50 34,30 +7,52% 13,08% 10.860
28/10/2005 32,00 32,60 30,60 31,90 +0,00% 6,25% 5.400
27/10/2005 31,50 31,90 30,20 31,90 +3,24% 5,40% 4.350
26/10/2005 31,50 31,50 30,20 30,90 +2,66% 4,13% 2.580
25/10/2005 30,50 31,00 30,10 30,10 -1,18% 2,95% 2.800
24/10/2005 30,30 30,74 30,10 30,46 +1,20% 2,11% 4.020
21/10/2005 30,30 30,30 30,10 30,10 +0,33% 0,66% 1.610
20/10/2005 31,80 31,80 30,00 30,00 -1,32% 5,66% 3.180
19/10/2005 30,50 31,00 30,00 30,40 +0,66% 3,28% 2.320
18/10/2005 31,00 31,00 30,00 30,20 -0,98% 3,23% 3.240
17/10/2005 30,50 31,00 29,20 30,50 +1,67% 5,90% 7.780
14/10/2005 29,70 30,00 29,50 30,00 -0,33% 1,68% 3.960
13/10/2005 30,00 30,10 29,39 30,10 +0,33% 2,37% 2.330
12/10/2005 30,00 30,40 29,70 30,00 +0,33% 2,33% 3.120
11/10/2005 29,00 30,50 29,00 29,90 -0,33% 5,17% 7.200
10/10/2005 30,70 30,70 30,00 30,00 -1,64% 2,28% 1.710
07/10/2005 29,90 30,50 29,80 30,50 +1,67% 2,34% 1.150
06/10/2005 30,40 30,90 29,50 30,00 -1,32% 4,61% 3.890
05/10/2005 30,10 30,40 29,60 30,40 -0,65% 2,66% 9.190
04/10/2005 30,50 31,50 30,00 30,60 +2,00% 4,92% 9.590
03/10/2005 30,00 30,30 29,22 30,00 +0,33% 3,60% 6.810
30/09/2005 29,70 30,20 29,70 29,90 +1,36% 1,68% 2.370
29/09/2005 29,50 29,80 29,20 29,50 +0,00% 2,03% 4.320
28/09/2005 30,00 30,00 29,28 29,50 -0,57% 2,40% 930
27/09/2005 29,50 29,80 29,28 29,67 +1,61% 1,76% 1.410